VAUGHN HOBLET: Open Payments
NPI 1205277464 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,569 in 95 payments from 20 companies in 2025. Trend: 2023 $2,861 · 2024 $3,868 · 2025 $7,569
Speaker / faculty: $4,950Food & beverage: $2,044Travel & lodging: $575
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 16 | $6,021 |
| ABBVIE INC. | 13 | $197 |
| AstraZeneca Pharmaceuticals LP | 5 | $188 |
| Novo Nordisk Inc | 12 | $169 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $154 |
| Merck Sharp & Dohme LLC | 6 | $120 |
| PFIZER INC. | 7 | $119 |
| Lilly USA, LLC | 4 | $76 |
| Lundbeck LLC | 3 | $74 |
| Exact Sciences Corporation | 4 | $66 |
Products named: DEXCOM G7 GSS (161), Kerendia, REXULTI, BREZTRI, Ozempic, VERQUVO, VRAYLAR, JARDIANCE.
Industry payments across OH — which companies pay providers there.
